Timely diagnosis of incubating syphilis infections using Treponema pallidum Transcription Mediated Amplification assay.
Ontology highlight
ABSTRACT: Syphilis is a complex multistage sexually transmitted infection (STI) caused by the bacterium Treponema pallidum subspecies pallidum (TP). New diagnostic tools are needed to minimize transmission. This study aimed to assess the additional value of an investigational Transcription Mediated Amplification test for TP (TP-TMA) to routine diagnostics. Between September 2021 and August 2022, visits of all participants of the national PrEP program at the sexual health center (SHC) in Amsterdam were included. Anal, pharyngeal, vaginal and urine samples collected for Chlamydia trachomatis and Neisseria gonorrhoeae screening, were additionally tested with the TP-TMA assay based on detection of 23S rRNA of TP. In total, 9974 SHC visits from 3283 participants were included. There were 191 infectious syphilis cases diagnosed; 26 (14%) primary syphilis, 54 (29%) secondary syphilis and 111 (58%) early latent syphilis. In 79/191 (41%) of these syphilis cases at least one sample was TP-TMA positive. For 16 participants, the positive TP-TMA result was not concordant with routine diagnostics. Of those, two participants were treated for syphilis within a week before the visit. Eight participants were treated for a syphilis notification at the visit or for another STI. Five participants were diagnosed with syphilis in the following visit and one participant was lost to follow-up. Adding the TP-TMA assay to routine diagnostics, we identified 14/191 (7%) additional syphilis infections among participants of the national PrEP program. The TP-TMA assay is a useful diagnostic tool to increase syphilis case finding and thus limit the transmission of syphilis.
SUBMITTER: Zondag HCA
PROVIDER: S-EPMC10724458 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA